The Centers for Disease Control and Prevention on Sept. 8 said research shows that antibodies produced by a prior COVID-19 infection or existing vaccines were good enough to protect against a new variant that has been found in the United States.
The CDC suggested in its update that the data are “encouraging” for the latest COVID-19 vaccine booster shot, which is currently being reviewed by federal health agencies. The Food and Drug Administration is scheduled to authorize updated vaccines that target subvariants of Omicron.
